Document is current

Article History

Received: 6 February 2020

Revised: 7 September 2020

Accepted: 11 September 2020

First Online: 14 October 2020

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center. Informed consent was waived. This study was performed in accordance with the Declaration of Helsinki.

: Not applicable.

: Data will be available on request.

: The authors declare no competing interests.

: S.P.N. is funded by the Australian Postgraduate Award, the Royal Australian and New Zealand College of Radiologists (RANZCR) Research Grant and the Radiological Society of North America (RSNA) Fellow Grant. C.D.F. was supported by Andrew Sabin Family Fellowship. C.D.F. received funding support from the National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research (NIDCR) (1R01DE025248-01/R56DE025248-01). C.D.F. was previously funded via the National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF DMS-1557679) and is currently supported by the NIH National Cancer Institute (NCI)/Big Data to Knowledge (BD2K) Program (1R01CA214825-01), the NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Career Development Award (P50CA097007-10); the NCI Paul Calabresi Clinical Oncology Program Award (K12 CA088084-06); a General Electric Healthcare/MD Anderson Center for Advanced Biomedical Imaging In-Kind Award; an Elekta AB/MD Anderson Department of Radiation Oncology Seed Grant; the Center for Radiation Oncology Research (CROR) at MD Anderson Cancer Center Seed Grant and the MD Anderson Institutional Research Grant (IRG) Program. C.D.F. has received speaker travel funding from Elekta AB. This study was supported in part by the NIH/NCI Cancer Center Support (Core) Grant CA016672 to The University of Texas MD Anderson Cancer Center (P30 CA016672). F.M.J. has received research funding from PIQUR Therapeutics and Trovagene. E.M.S. has a research award from Roche Diagnostics supporting HPV testing of oral rinse and mucosal swab samples on the clinical trial for HPV-related cancers screening in men (HOUSTON study).